Perioperative Multimodal Analgesia for Supratentorial Craniotomy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Tiantan Hospital
About this trial
This randomized clinical trial aims to evaluate the effectiveness of scalp nerve blocks and dexmedetomidine in reducing opioid use and preventing postoperative delirium in patients undergoing supratentorial brain tumor surgery. A total of 2000 patients will be randomly assigned to one of four groups, receiving either active treatments, placebos, or their combinations. The main outcome measured will be the amount of opioid pain medication needed after surgery.
Eligibility criteria
Qualifiers
Aged from 18 to 65 years
American Society of Anesthesiologists physical status I to III
Scheduled to undergo elective supratentorial tumor resection
Disqualifiers
Incision-area skin infection
A history of previous craniotomy
Allergy to study medications
A history of preoperative change in consciousness or cognitive function
Trial design
Treatments tested in this trial
- Dexmedetomidine
- Scalp-Nerve Block
Treatment groups
2,000 Participants
are divided into 4 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov